The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 1, 2024 | Israel Biotech Fund I, L.P. | Director, 10% Owner | Option exercise(M) | 3.8M | — | — |
| Mar 1, 2024 | Israel Biotech Fund I, L.P. | Director, 10% Owner | Option exercise(M) | 3.8M | — | — |
| Mar 1, 2024 | Israel Biotech Fund I, L.P. | Director, 10% Owner | Option exercise(M) | 2.3M | — | — |
| Mar 1, 2024 | Israel Biotech Fund I, L.P. | Director, 10% Owner | Option exercise(M) | 1.5M | — | — |
| Mar 1, 2024 | Israel Biotech Fund I, L.P. | Director, 10% Owner | Option exercise(M) | 2.3M | — | — |
| Mar 1, 2024 | Israel Biotech Fund I, L.P. | Director, 10% Owner | Option exercise(M) | 1.5M | — | — |
| Feb 7, 2024 | Israel Biotech Fund GP Partners, L.P. | Director, 10% Owner | Option exercise(M) | 1.9M | $0.40 | $770K |
| Feb 7, 2024 | Israel Biotech Fund GP Partners, L.P. | Director, 10% Owner | Option exercise(M) | 4.2M | $0.40 | $1.7M |
| Feb 7, 2024 | Israel Biotech Fund GP Partners, L.P. | Director, 10% Owner | Option exercise(M) | 3.9M | $0.40 | $1.6M |
| Feb 7, 2024 | Israel Biotech Fund GP Partners, L.P. | Director, 10% Owner | Tax withholding(F) | 2.6M | $1.25 | $3.2M |
| Feb 7, 2024 | Israel Biotech Fund GP Partners, L.P. | Director, 10% Owner | Option exercise(M) | 8.4M | $0.40 | $3.4M |
| Feb 7, 2024 | Israel Biotech Fund GP Partners, L.P. | Director, 10% Owner | Tax withholding(F) | 2.7M | $1.25 | $3.4M |
| Feb 7, 2024 | Israel Biotech Fund GP Partners, L.P. | Director, 10% Owner | Option exercise(M) | 8.1M | $0.40 | $3.2M |
| Feb 7, 2024 | Israel Biotech Fund GP Partners, L.P. | Director, 10% Owner | Option exercise(M) | 1.3M | $0.40 | $518K |
| Feb 7, 2024 | Israel Biotech Fund GP Partners, L.P. | Director, 10% Owner | Option exercise(M) | 3.9M | — | — |
| Feb 7, 2024 | Israel Biotech Fund GP Partners, L.P. | Director, 10% Owner | Option exercise(M) | 8.1M | — | — |
| Feb 7, 2024 | Israel Biotech Fund GP Partners, L.P. | Director, 10% Owner | Option exercise(M) | 1.3M | — | — |
| Feb 7, 2024 | Israel Biotech Fund GP Partners, L.P. | Director, 10% Owner | Option exercise(M) | 8.4M | — | — |
| Feb 7, 2024 | Israel Biotech Fund GP Partners, L.P. | Director, 10% Owner | Option exercise(M) | 1.9M | — | — |
| Feb 7, 2024 | Israel Biotech Fund GP Partners, L.P. | Director, 10% Owner | Option exercise(M) | 4.2M | — | — |
| Nov 17, 2023 | Israel Biotech Fund GP Partners, L.P. | 10% Owner | Buy(P) | 3.1M | — | — |
| Nov 17, 2023 | Israel Biotech Fund GP Partners, L.P. | 10% Owner | Buy(P) | 3.1M | — | — |
| Nov 17, 2023 | Israel Biotech Fund GP Partners, L.P. | 10% Owner | Buy(P) | 4.7M | — | — |
| Nov 17, 2023 | Israel Biotech Fund GP Partners, L.P. | 10% Owner | Buy(P) | 5.6M | — | — |
| Nov 17, 2023 | Israel Biotech Fund GP Partners, L.P. | 10% Owner | Buy(P) | 0 | — | — |
| Nov 17, 2023 | Israel Biotech Fund GP Partners, L.P. | 10% Owner | Buy(P) | 0 | — | — |
| Nov 17, 2023 | Israel Biotech Fund GP Partners, L.P. | 10% Owner | Buy(P) | 2.8M | — | — |
| Nov 17, 2023 | Israel Biotech Fund GP Partners, L.P. | 10% Owner | Buy(P) | 6.2M | — | — |
| Nov 17, 2023 | Israel Biotech Fund GP Partners, L.P. | 10% Owner | Buy(P) | 6.2M | — | — |
| Nov 17, 2023 | Israel Biotech Fund GP Partners, L.P. | 10% Owner | Buy(P) | 10.3M | — | — |
| Oct 18, 2023 | aMoon Growth Fund Limited Partnership | 10% Owner | Other(J) | 0 | — | $0 |
| Oct 18, 2023 | Israel Biotech Fund GP Partners II, L.P. | 10% Owner | Buy(P) | 659K | — | $0 |
| Oct 18, 2023 | Israel Biotech Fund GP Partners II, L.P. | 10% Owner | Buy(P) | 659K | — | $0 |
| Sep 1, 2023 | Israel Biotech Fund II, L.P. | 10% Owner | Buy(P) | 0 | $1,500,000.00 | $0 |
| Sep 1, 2023 | Israel Biotech Fund II, L.P. | 10% Owner | Buy(P) | 0 | $500,000.00 | $0 |
| Sep 1, 2023 | Israel Biotech Fund GP Partners II, L.P. | 10% Owner | Buy(P) | 0 | $500,000.00 | $0 |
| Sep 1, 2023 | Israel Biotech Fund GP Partners II, L.P. | 10% Owner | Buy(P) | 0 | $1,500,000.00 | $0 |
| Jan 19, 2023 | Spiegel Robert J. | Director | Grant(A) | 3K | — | — |
| Jan 19, 2023 | Spiegel Robert J. | Director | Grant(A) | 1K | — | — |
| Jan 19, 2023 | Spiegel Robert J. | Director | Grant(A) | 1K | — | — |
| Jan 19, 2023 | Spiegel Robert J. | Director | Grant(A) | 2K | — | — |
| Jan 19, 2023 | Bisker-Leib Vered | Director | Grant(A) | 2K | — | — |
| Jan 19, 2023 | Bisker-Leib Vered | Director | Grant(A) | 1K | — | — |
| Jan 19, 2023 | Bisker-Leib Vered | Director | Grant(A) | 1K | — | — |
| Jan 19, 2023 | Goldberg Murray A | Director | Grant(A) | 1K | — | — |
| Jan 19, 2023 | Goldberg Murray A | Director | Grant(A) | 1K | — | — |
| Jan 19, 2023 | Goldberg Murray A | Director | Grant(A) | 2K | — | — |
| Jan 19, 2023 | Goldberg Murray A | Director | Grant(A) | 3K | — | — |
| Jan 19, 2023 | Sidransky David | Director | Grant(A) | 46 | — | — |
| Jan 19, 2023 | Sidransky David | Director | Grant(A) | 2K | — | — |
| Jan 19, 2023 | Sidransky David | Director | Grant(A) | 2K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).